Mir-204 Controls Glucagon-Like Peptide 1 Receptor Expression and Agonist Function.

about

Diabetes pathogenic mechanisms and potential new therapies based upon a novel target called TXNIP.Metazoan MicroRNAs

P2860

Q52709221-B2287FCF-F0C1-49B5-BE93-CABB13A54BC7 Q56140779-F25F1B14-D64B-4564-9F8D-70DABEB6690E

P2860

Mir-204 Controls Glucagon-Like Peptide 1 Receptor Expression and Agonist Function.

Item

http://www.wikidata.org/entity/Q47443146

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Mir-204 Controls Glucagon-Like Peptide 1 Receptor Expression and Agonist Function.

@en

Mir-204 Controls Glucagon-Like Peptide 1 Receptor Expression and Agonist Function.

@nl

type

Item

label

Mir-204 Controls Glucagon-Like Peptide 1 Receptor Expression and Agonist Function.

@en

Mir-204 Controls Glucagon-Like Peptide 1 Receptor Expression and Agonist Function.

@nl

prefLabel

Mir-204 Controls Glucagon-Like Peptide 1 Receptor Expression and Agonist Function.

@en

Mir-204 Controls Glucagon-Like Peptide 1 Receptor Expression and Agonist Function.

@nl

P1476

miR-204 Controls Glucagon-Like Peptide 1 Receptor Expression and Agonist Function

@en

P2093

Guanlan Xu

http://www.w3.org/2001/XMLSchema#string

Junqin Chen

http://www.w3.org/2001/XMLSchema#string

Lance A Thielen

http://www.w3.org/2001/XMLSchema#string

SeongHo Jo

http://www.w3.org/2001/XMLSchema#string

Truman B Grayson

http://www.w3.org/2001/XMLSchema#string

P2860

Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function

A mammalian microRNA expression atlas based on small RNA library sequencing

β-Cell MicroRNAs: Small but Powerful

Thioredoxin-interacting protein is stimulated by glucose through a carbohydrate response element and induces beta-cell apoptosis

Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis

Exenatide inhibits beta-cell apoptosis by decreasing thioredoxin-interacting protein

A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice.

Lack of TXNIP protects against mitochondria-mediated apoptosis but not against fatty acid-induced ER stress-mediated beta-cell death.

The identification of novel proteins that interact with the GLP-1 receptor and restrain its activity

Deletion of the alpha-arrestin protein Txnip in mice promotes adiposity and adipogenesis while preserving insulin sensitivity.

P304

256-264

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB17-0506

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Anath Shalev

P577

2017-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29101219

http://www.w3.org/2001/XMLSchema#string

P932

5780066

http://www.w3.org/2001/XMLSchema#string

Mir-204 Controls Glucagon-Like Peptide 1 Receptor Expression and Agonist Function.

about

P2860

P2860

Mir-204 Controls Glucagon-Like Peptide 1 Receptor Expression and Agonist Function.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932